These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 6401196)

  • 1. T-lymphocyte subpopulations in patients with classic hemophilia treated with cryoprecipitate and lyophilized concentrates.
    Menitove JE; Aster RH; Casper JT; Lauer SJ; Gottschall JL; Williams JE; Gill JC; Wheeler DV; Piaskowski V; Kirchner P; Montgomery RR
    N Engl J Med; 1983 Jan; 308(2):83-6. PubMed ID: 6401196
    [No Abstract]   [Full Text] [Related]  

  • 2. Impaired cell-mediated immunity in patients with classic hemophilia.
    Lederman MM; Ratnoff OD; Scillian JJ; Jones PK; Schacter B
    N Engl J Med; 1983 Jan; 308(2):79-83. PubMed ID: 6216408
    [No Abstract]   [Full Text] [Related]  

  • 3. AIDS and preventive treatment in hemophilia.
    Desforges JF
    N Engl J Med; 1983 Jan; 308(2):94-5. PubMed ID: 6216409
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunologic dysfunction in patients with classic hemophilia receiving lyophilized factor VIII concentrates and cryoprecipitate.
    Tsoukas C; Gervais F; Fuks A; Guttmann RD; Strawczynski H; Shuster J; Gold P
    Can Med Assoc J; 1983 Oct; 129(7):713-7. PubMed ID: 6225504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The course of preexistent immune abnormalities in HIV negative haemophiliacs treated for two years with a monoclonal purified factor VIII concentrate.
    Smid WM; van der Meer J; Smit JW; Halie MR
    Thromb Haemost; 1993 Apr; 69(4):306-10. PubMed ID: 8388579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired cell-mediated immunity in hemophilia. II. Persistence of subclinical immunodeficiency and enhancement of natural killer activity by lymphokines.
    Lederman MM; Ratnoff OD; Schacter B; Shoger T
    J Lab Clin Med; 1985 Aug; 106(2):197-204. PubMed ID: 2410523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transfusion support for haemophiliacs.
    Allain JP
    Clin Haematol; 1984 Feb; 13(1):99-117. PubMed ID: 6426835
    [No Abstract]   [Full Text] [Related]  

  • 8. Coincident classic hemophilia and "idiopathic" thrombocytopenic purpura in patients under treatment with concentrates of antihemophilic factor (factor VIII).
    Ratnoff OD; Menitove JE; Aster RH; Lederman MM
    N Engl J Med; 1983 Feb; 308(8):439-42. PubMed ID: 6401839
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of chronic factor VIII substitution on immune parameters in HIV seronegative haemophiliacs: a comparison between cryoprecipitate and factor VIII concentrate.
    Allersma DP; Smid WM; van der Does JA; van der Meer J; Briët E
    Thromb Haemost; 1996 Feb; 75(2):261-6. PubMed ID: 8815573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologic status of hemophilia patients treated with cryoprecipitate or lyophilized concentrate.
    Gjerset GF; Martin PJ; Counts RB; Fast LD; Hansen JA
    Blood; 1984 Sep; 64(3):715-20. PubMed ID: 6235871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological alterations in haemophiliacs treated with lyophilized Factor VIII cryoprecipitate from volunteer donors.
    Ceuppens JL; Vermylen J; Colaert J; Desmyter J; Gautama K; Stevens E; The AL; Vanham G; Vermylen C; Verstraete M
    Thromb Haemost; 1984 Apr; 51(2):207-11. PubMed ID: 6429883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-cell alterations in hemophiliacs treated with commercial clotting factor concentrates.
    Lechner K; Niessner H; Bettelheim P; Deutsch E; Fasching I; Fuhrmann M; Hinterberger W; Korninger C; Neumann E; Liszka K
    Thromb Haemost; 1983 Aug; 50(2):552-6. PubMed ID: 6314582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficiency of the autologous mixed lymphocyte reaction in patients with classic hemophilia treated with commercial factor VIII concentrate. Correlation with T cell subset distribution, antibodies to lymphadenopathy-associated or human T lymphotropic virus, and analysis of the cellular basis of the deficiency.
    Smolen JS; Bettelheim P; Köller U; McDougal S; Graninger W; Luger TA; Knapp W; Lechner K
    J Clin Invest; 1985 Jun; 75(6):1828-34. PubMed ID: 2989334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HTLV-I antibody status in hemophilia patients treated with factor concentrates prepared from U.S. plasma sources and in hemophilia patients with AIDS.
    Chorba TL; Jason JM; Ramsey RB; Lechner K; Pabinger-Fasching I; Kalyanaraman VS; McDougal JS; Cabradilla CD; Tregillus LC; Lawrence DN
    Thromb Haemost; 1985 Apr; 53(2):180-2. PubMed ID: 2992112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Some complications of the therapy of classic hemophilia.
    Ratnoff OD
    J Lab Clin Med; 1984 May; 103(5):653-9. PubMed ID: 6425440
    [No Abstract]   [Full Text] [Related]  

  • 16. AIDS in a patient with hemophilia receiving mainly cryoprecipitate.
    Gerstein HC; Fanning MM; Read SE; Shepherd FA; Glynn MF
    Can Med Assoc J; 1984 Jul; 131(1):45-7. PubMed ID: 6428732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemophilia and acquired immune deficiency syndrome.
    Levine PH; Brettler DB; Sullivan JL
    Prog Clin Biol Res; 1985; 182():287-96. PubMed ID: 2994104
    [No Abstract]   [Full Text] [Related]  

  • 18. The management of musculoskeletal problems in hemophilia. Part I. Principles of medical management of hemophilia.
    McMillan CW; Greene WB; Blatt PM; White GC; Roberts HR
    Instr Course Lect; 1983; 32():210-6. PubMed ID: 6443730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HTLV-III infection in homosexuals and hemophiliacs in Sweden.
    Biberfeld G; Böttiger B; Karlsson A; Sandström E; Morfeldt-Månsson L; Blombäck M; Nilsson IM; Wiechel B; Saxinger C; Gallo R
    Cancer Res; 1985 Sep; 45(9 Suppl):4609s-4611s. PubMed ID: 2990693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in CD4 count relative to product usage: findings from the transfusion safety study.
    Hilgartner MW
    Semin Hematol; 1993 Oct; 30(4 Suppl 5):7-9. PubMed ID: 7903481
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.